According to Meinong Biotech, the controlling shareholder and actual controller of the company, Mr. Hong Wei, and his co-actors, Quan Yu and Ms. Hong Jun, the total shareholding ratio changed from 45.67% to 44.97% when the company implemented capital transfers from the Capital Provident Fund, repurchase shares cancellation, and restricted stock incentive plans. Among them, Quanyu reduced its holdings by 1.069,800 shares through centralized bidding between January 28, 2026 and August 6, 2026, with a reduction ratio of 0.76%; the shareholding ratio was passively reduced by 0.26% due to belonging to the 2025 Restricted Stock Incentive Plan.

Zhitongcaijing · 2d ago
According to Meinong Biotech, the controlling shareholder and actual controller of the company, Mr. Hong Wei, and his co-actors, Quan Yu and Ms. Hong Jun, the total shareholding ratio changed from 45.67% to 44.97% when the company implemented capital transfers from the Capital Provident Fund, repurchase shares cancellation, and restricted stock incentive plans. Among them, Quanyu reduced its holdings by 1.069,800 shares through centralized bidding between January 28, 2026 and August 6, 2026, with a reduction ratio of 0.76%; the shareholding ratio was passively reduced by 0.26% due to belonging to the 2025 Restricted Stock Incentive Plan.